Market Price Fluctuations and Valuation Losses on Investment Securities
First written in FY2019. 9 of 18 entries say "Mitigated", first in FY2023-Q1. Latest entry: FY2026.
The whole theme swung hardest in 2019: 54 of 136 companies on the "Worse" side.
- FY2026MaterialisedAnnual report
「During the current consolidated fiscal year, impairment losses of ¥9.999 million were recognized on securities, comprising ¥9.999 million on equity investments classified as other securities.」
A valuation loss of ¥9.999 million was newly recognized on equity investments classified as other securities in connection with the risk of market price movements. - FY2026-H1MitigatedAnnual report
「Valuation difference on other securities 22,004 26,831」
The valuation difference on other securities increased from ¥22.004 million at the end of the previous fiscal year to ¥26.831 million, widening the valuation difference. - FY2025WorsenedAnnual report
「Equities 98,848 67,150 31,697」
The valuation difference on equity investments classified as other securities narrowed from ¥37.846 million in the previous fiscal year to ¥31.697 million, indicating a deterioration in valuation differences resulting from market price movements. - FY2025-H1WorsenedAnnual report
「Valuation difference on other securities 26,273 20,685」
The valuation difference on other securities decreased from ¥26.273 million at the end of the previous consolidated fiscal year to ¥20.685 million, narrowing the valuation difference. - FY2024MitigatedAnnual report
「Equities 104,770 66,923 37,846」
The valuation difference on equity investments classified as other securities widened from ¥27.535 million in the previous fiscal year to ¥37.846 million, indicating an improvement in valuation differences resulting from market price movements. - FY2024-Q3MitigatedAnnual report
「Valuation difference on other securities 19,114 24,322」
The valuation difference on other securities increased from ¥19.114 million at the end of the previous consolidated fiscal year to ¥24.322 million, widening the valuation difference. - FY2024-Q2MitigatedAnnual report
「Valuation difference on other securities 19,114 25,320」
The valuation difference on other securities increased from ¥19.114 million at the end of the previous consolidated fiscal year to ¥25.320 million, widening overall. - FY2024-Q1MitigatedAnnual report
「Valuation difference on other securities 19,114 22,964」
The valuation difference on other securities increased from ¥19.114 million at the end of the previous consolidated fiscal year to ¥22.964 million, widening overall. - FY2023MitigatedAnnual report
「Shares 94,270 66,735 27,535」
The valuation difference on shares classified as other securities widened from ¥21.022 million in the previous fiscal year to ¥27.535 million, indicating an improvement in the valuation difference caused by market-price fluctuations. - FY2023-Q3MitigatedAnnual report
「Valuation difference on other securities 14,593 19,069」
The valuation difference on other securities increased from ¥14.593 million at the end of the previous consolidated fiscal year to ¥19.069 million, widening overall. - FY2023-Q2MitigatedAnnual report
「Valuation difference on other securities 14,593 17,169」
The valuation difference on other securities increased from ¥14.593 million at the end of the previous consolidated fiscal year to ¥17.169 million, widening overall. - FY2023-Q1MitigatedAnnual report
「Valuation difference on other securities 14,593 16,989」
The valuation difference on other securities increased from ¥14.593 million at the end of the previous consolidated fiscal year to ¥16.989 million, widening overall. - FY2022WorsenedAnnual report
「Shares 87,576 66,553 21,022」
The valuation difference on shares classified as other securities narrowed from ¥31.112 million in the previous fiscal year to ¥21.022 million, and the deterioration in valuation differences caused by market-price fluctuations continued. - FY2022-Q3WorsenedAnnual report
「Valuation difference on other securities 21,598 17,215」
The valuation difference on other securities declined from ¥21.598 million at the end of the previous fiscal year to ¥17.215 million, narrowing overall. - FY2022-Q1WorsenedAnnual report
「Valuation difference on other securities 21,598 20,605」
The valuation difference on other securities declined from ¥21.598 million at the end of the previous fiscal year to ¥20.605 million, and a ¥992 thousand decrease in the valuation difference was recognized in other comprehensive income. - FY2021MaterialisedAnnual report
「Loss on sale of investment securities – 4,000」
The company recognized a ¥4 million loss on the sale of investment securities during the current fiscal year, with losses related to market-price fluctuations and other factors appearing in its results. The balance-sheet carrying amount of the shares held was ¥97.490 million, and the valuation difference was ¥31.112 million. - FY2020WorsenedAnnual report
「80,829 66,208 14,620」
The balance-sheet carrying amount of shares classified as other securities declined from ¥119.193 million in the previous fiscal year to ¥80.829 million, while the valuation difference declined from ¥53.149 million to ¥14.620 million. No impairment loss was recognized during the current fiscal year, however. - FY2019MaterialisedAnnual report
「Investment securities consist mainly of bonds held to maturity and shares of companies with business relationships, and are exposed to market price fluctuation risk. During the fiscal year, the Company recognized an impairment loss of ¥112 million on securities, consisting of ¥112 million on shares classified as other securities.」
The filing identifies market price fluctuation risk in investment securities and reports a ¥112 million impairment loss on shares during the fiscal year.